GlassScriptPhysician profile
James W Long
NPI 1518906742
$633,632.93
in general payments reported to CMS, 2019-2025
11 companies · $195K in 2025
The $195K reported for 2025 was more than what 99% of Thoracic Surgery (Cardiothoracic Vascular Surgery) providers received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $45K · 2020: $411 · 2021: $46.95 · 2022: $1,371 · 2023: $12.86 · 2024: $391K · 2025: $195K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $586K · Food and Beverage: $278.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $586,071.00 |
| Food and Beverage | $278.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Briohealth Solutions, INC. | $586,071.00 | 2024-2025 | Briovad |
| Abbott Laboratories | $46,518.30 | 2019-2022 | |
| W. L. Gore & Associates, INC. | $241.37 | 2019-2020 | |
| Allergan, INC. | $218.31 | 2019-2020 | |
| Abiomed | $192.60 | 2024 | Impella |
| Boston Scientific Corporation | $119.42 | 2019 | |
| Medtronic Vascular, INC. | $100.79 | 2019 | |
| Endologix LLC | $72.80 | 2024 | Torus Stent Graft System, Endocross Device |
| Abbvie INC. | $56.87 | 2021-2022 | |
| Medtronic, INC. | $28.61 | 2022 | |
| Impulse Dynamics (USA) INC. | $12.86 | 2023 | Optimizer |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Long listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.